OpenEvidence News
Latest news, updates, and announcements from OpenEvidence.
OpenEvidence nears $30B valuation as healthcare AI platform proves vertical specialization can outrun general-purpose models.
What happened: OpenEvidence, a Boston-based startup building a clinical AI chatbot for physicians, has received a $200 million investment offer that would value the company at approximately $20 billio...
OpenEvidence reached a 12 billion valuation following a 250 million Series D, hitting a 100 million...
OpenEvidence reached a 12 billion valuation following a 250 million Series D, hitting a 100 million revenue run rate in under 12 months. With 430,000 clinicians generating 20 million monthly conversat...
OpenEvidence reached a 12 billion dollar valuation after a 250 million dollar funding round led by T...
OpenEvidence reached a 12 billion dollar valuation after a 250 million dollar funding round led by Thrive Capital. Used by 50 percent of U.S. physicians and processing 18 million monthly consultations...
OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as...
OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as the primary AI infrastructure for U.S. healthcare. With 40 percent of domestic physicians already u...
OpenEvidence, the "ChatGPT for doctors," recently secured $250M, elevating its valuation to $12B. Th...
OpenEvidence, the "ChatGPT for doctors," recently secured $250M, elevating its valuation to $12B. This remarkable leap from $6B in October is fueled by over $100M in annual revenue from healthcare sub...